Literature DB >> 1988111

Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid.

J Hansson1, K Berhane, V M Castro, U Jungnelius, B Mannervik, U Ringborg.   

Abstract

Glutathione transferases are enzymes implied in the resistance of tumor cells to bifunctional alkylating cytostatic drugs. We have investigated the effect of the glutathione transferase inhibitor by ethacrynic acid on the cytotoxicity of melphalan to a human melanoma cell line (RPMI 8322) with a high level of glutathione transferase activity. Using 1-chloro-2,4-dinitrobenzene as substrate, ethacrynic acid was shown to inhibit the activity of purified human glutathione transferases, with 50% inhibition values of 1, 10, and 15 microM for transferase mu (class mu), transferase epsilon (class alpha) and transferase pi (class pi), respectively, all of which occur in RPMI 8322 cells. Ethacrynic acid at a concentration of 20 microM, which by itself was noncytotoxic, increased the cytotoxicity of melphalan to RPMI 8322 human melanoma cells approximately 2-fold. The induction of DNA interstrand cross-links by 40 microM melphalan was increased 1.4-fold by 30 microM ethacrynic acid. These results indicate that a potentiation of the cytotoxic effect of bifunctional alkylating agents can be achieved by inhibition of glutathione transferase and that the enhanced cytotoxicity may be caused at least in part by increased formation of drug-DNA adducts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988111

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Glutathione conjugation of chlorambucil: measurement and modulation by plant polyphenols.

Authors:  K Zhang; K P Wong
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

Review 2.  Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2018-06-18       Impact factor: 5.153

3.  Co-variation of glutathione transferase expression and cytostatic drug resistance in HeLa cells: establishment of class Mu glutathione transferase M3-3 as the dominating isoenzyme.

Authors:  X Y Hao; M Widersten; M Ridderström; U Hellman; B Mannervik
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

Review 4.  Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; K Guth; R Landsiedel
Journal:  Arch Toxicol       Date:  2014-11-05       Impact factor: 5.153

5.  Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line.

Authors:  A Canada; L Herman; K Kidd; C Robertson; D Trump
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Monobromobimane occupies a distinct xenobiotic substrate site in glutathione S-transferase pi.

Authors:  Luis A Ralat; Roberta F Colman
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

7.  Glutathione S-transferase-mediated metabolism of glyceryl trinitrate in subcellular fractions of bovine coronary arteries.

Authors:  D T Lau; E K Chan; L Z Benet
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

8.  Activity of melphalan in combination with the glutathione transferase inhibitor sulfasalazine.

Authors:  V Gupta; J P Jani; S Jacobs; M Levitt; L Fields; S Awasthi; B H Xu; M Sreevardhan; Y C Awasthi; S V Singh
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Increased levels of glutathione S-transferase pi transcript as a mechanism of resistance to ethacrynic acid.

Authors:  S Kuzmich; L A Vanderveer; E S Walsh; F P LaCreta; K D Tew
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

10.  Isozyme specificity of novel glutathione-S-transferase inhibitors.

Authors:  J E Flatgaard; K E Bauer; L M Kauvar
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.